The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...

The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...

Island Pharmaceuticals has signed an asset purchase agreement to buy the Galidesivir antiviral program targeting ...

In the shadows of Python Cave, Uganda, a leopard leaps from a guano mound—formed by bat excrement—and sinks its teeth into a ...

The West African country of Equatorial Guinea declared an outbreak of the Marburg virus disease in mid-February. There have been at least nine laboratory-confirmed cases, seven of which resulted ...

The filoviruses Ebola and Marburg use several different and effective mechanisms to both evade and battle the immune system. This Review explores recent findings in the filovirus–host-defence ...

Marburg virus is a zoonotic virus that, along with the six species of Ebola virus, comprises the filovirus family, the CDC said. The rare virus was first identified in 1967 after it caused ...

The Marburg virus, while rare, is known to cause severe hemorrhagic fever and has a high mortality rate of up to 88 percent. It is typically spread to humans from fruit bats, ...

The fatality ratio of the Marburg virus, which is “in the same family as the virus that causes Ebola,” ranges from 24% to 88% depending on case severity, according to WHO.

Marburg virus is not airborne. One piece of good news that Dr. Siegel shared: Unlike the COVID-19 virus, the Marburg virus does not spread through the air.

Without treatment, Marburg can be fatal in up to 88% of people who fall ill with the disease. There are currently no approved vaccines or treatments specifically for this virus.

Marburg virus disease, or MVD is a serious, often fatal disease. The virus causes a severe viral hemorrhagic fever, according to the World Health Organization.